This is an updated version of the original Cochrane review published in Issue 11, 2013.Severe myoclonic epilepsy in infants (SMEI), also known as Dravet syndrome, is a rare, refractory form of epilepsy, for which stiripentol (STP) has been recently licensed as add-on therapy.
|Titolo:||Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy|
BRIGO, Francesco (Corresponding)
|Data di pubblicazione:||2015|
|Appare nelle tipologie:||01.01 Articolo in Rivista|